3 not yet recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Not yet recruiting 3 |
Follow ivarmacitinib: new trials by email Literature Review of ivarmacitinib trials Research Report on ivarmacitinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ivarmacitinib With or Without Celecoxib for Ankylosing Spondylitis Ivarmacitinib with celecoxib, Ivarmacitinib Monotherapy - Ankylosing Spondylitis (AS) | Phase 4 | Not yet recruiting | Peking University Third Hospital | 138 | 2026-10-25 | 2026-10-27 |
| Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis Vanakizumab, Ivarmacitinib, Prednisone - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 180 | 2026-04-01 | 2026-03-05 |
| Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis Ivarmacitinib - Rheumatoid Arthritis | Phase 4 | Not yet recruiting | Tongji Hospital | 100 | 2026-03-01 | 2026-03-05 |
Arthritis, Rheumatoid (1) · Spondylitis, Ankylosing (1) · Takayasu Arteritis (1)
Chinese SLE Treatment And Research Group (1) · Peking University Third Hospital (1) · Tongji Hospital (1)
China (1)